A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/39 (2006.01) A61K 31/745 (2006.01) A61K 31/75 (2006.01) A61K 35/74 (2006.01)
Patent
CA 2135784
2135784 9323079 PCTABScor01 A non-specific host defense cell augmentation technique for enhanced microorganism killing utilizes any phagocytosable biocompatible particle to prime macrophages for enhanced oxidative response and bacterial killing. Patients can have the benefits of primed macrophages in one to four days, and experiments have demonstrated over a 100-fold increase in oxidative potential within this time period. The oxidative response and killing potential is non-immunospecific, meaning not one microorganism, not a vaccine, and broadly applicable simultaneously to bacteria and viruses as well as tumor cells. The effects have been demonstrated to have a seven day duration indicating non-tissue toxic residual effects and potential for repeated use at monthly intervals.
Gristina Anthony G.
Myrvik Quentin N.
Gristina Anthony G.
Macrae & Co.
LandOfFree
Method for nonspecific cellular immune stimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for nonspecific cellular immune stimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for nonspecific cellular immune stimulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1413956